PSI/EFSPI representation at two EMA workshops in March
Apr 04, 2017
PSI/EFSPI was represented at two EMA workshops in March. The First-in-Human (FIH) workshop occurred on March 28 where comments received during the public consultation for the revised ‘Guideline on strategies to identify and mitigate risks for first-in-human clinical trials with investigational medicinal products’ were discussed.
The workshop on Rare diseases was held on March 29-30, with the aim to translate and promote novel methodologies into recommendations to advance the clinical research and the development of medicines and new treatments for patients with a rare disease.